TreeWAS – Variant ID: rs13203429

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
L40 Psoriasis	1.000	0.000	0.000
J45.9 Asthma, unspecified	0.000	0.000	1.000
E03.9 Hypothyroidism, unspecified	0.000	0.001	0.999
E03 Other hypothyroidism	0.000	0.007	0.993
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.014	0.986
E00-E07 Disorders of thyroid gland	0.000	0.016	0.984
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.017	0.983
E05.9 Thyrotoxicosis, unspecified	0.000	0.021	0.979
C44 Other malignant neoplasms of skin	0.925	0.075	0.000
C44.2 Skin of ear and external auricular canal	0.922	0.078	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.079	0.921
C44.3 Skin of other and unspecified parts of face	0.912	0.088	0.000
C44.4 Skin of scalp and neck	0.896	0.104	0.000
E07 Other disorders of thyroid	0.000	0.149	0.851
C44.7 Skin of lower limb, including hip	0.848	0.152	0.000
L40.4 Guttate psoriasis	0.837	0.163	0.000
C44.5 Skin of trunk	0.828	0.172	0.000
L40.1 Generalised pustular psoriasis	0.809	0.191	0.000
J45 Asthma	0.000	0.197	0.803
C44.0 Skin of lip	0.789	0.211	0.000
L40.0 Psoriasis vulgaris	0.788	0.212	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.769	0.231	0.000
I25.9 Chronic ischaemic heart disease, unspecified	0.769	0.231	0.000
I25 Chronic ischaemic heart disease	0.769	0.231	0.000
L40.8 Other psoriasis	0.753	0.247	0.000
K90 Intestinal malabsorption	0.000	0.251	0.749
J45.0 Predominantly allergic asthma	0.000	0.257	0.743
I20-I25 Ischaemic heart diseases	0.719	0.281	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
E07.8 Other specified disorders of thyroid	0.000	0.287	0.713
E03.5 Myxoedema coma	0.000	0.288	0.712
E03.4 Atrophy of thyroid (acquired)	0.000	0.288	0.712
E03.3 Postinfectious hypothyroidism	0.000	0.288	0.712
E05.5 Thyroid crisis or storm	0.000	0.293	0.707
E05.4 Thyrotoxicosis factitia	0.000	0.293	0.707
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.293	0.707
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.293	0.707
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.294	0.706
E00 Congenital iodine-deficiency syndrome	0.000	0.294	0.706
L40.3 Pustulosis palmaris et plantaris	0.697	0.303	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.316	0.684
I22 Subsequent myocardial infarction	0.668	0.332	0.000
C44.8 Overlapping lesion of skin	0.663	0.337	0.000
E03.1 Congenital hypothyroidism without goitre	0.000	0.339	0.661
C44.1 Skin of eyelid, including canthus	0.657	0.343	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.655	0.345	0.000
J45.1 Nonallergic asthma	0.000	0.349	0.651
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.352	0.648
I25.2 Old myocardial infarction	0.634	0.366	0.000
E05.8 Other thyrotoxicosis	0.000	0.374	0.626
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.379	0.621
I23 Certain current complications following acute myocardial infarction	0.618	0.382	0.000
E03.8 Other specified hypothyroidism	0.000	0.384	0.616
K90.8 Other intestinal malabsorption	0.000	0.388	0.612
E07.1 Dyshormogenetic goitre	0.000	0.390	0.610
E07.0 Hypersecretion of calcitonin	0.000	0.390	0.610
C44.9 Malignant neoplasm of skin, unspecified	0.609	0.391	0.000
K90.9 Intestinal malabsorption, unspecified	0.000	0.392	0.608
I21 Acute myocardial infarction	0.599	0.401	0.000
I24 Other acute ischaemic heart diseases	0.593	0.407	0.000
I21.2 Acute transmural myocardial infarction of other sites	0.589	0.411	0.000
J45.8 Mixed asthma	0.000	0.424	0.576
I25.3 Aneurysm of heart	0.572	0.428	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.437	0.562
I25.6 Silent myocardial ischaemia	0.551	0.449	0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.544	0.456	0.000
K90.3 Pancreatic steatorrhoea	0.000	0.463	0.537
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.463	0.537
K90.1 Tropical sprue	0.000	0.463	0.537
I21.1 Acute transmural myocardial infarction of inferior wall	0.516	0.484	0.000
I24.8 Other forms of acute ischaemic heart disease	0.515	0.485	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.494	0.506
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.494	0.506
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.494	0.506
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.494	0.506
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.494	0.506
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.494	0.506
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.494	0.506
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.494	0.506
I22.8 Subsequent myocardial infarction of other sites	0.506	0.494	0.000
L40-L45 Papulosquamous disorders	0.505	0.495	0.000
I20 Angina pectoris	0.500	0.500	0.000
I25.0 Atherosclerotic cardiovascular disease, so described	0.500	0.500	0.000
I24.9 Acute ischaemic heart disease, unspecified	0.477	0.523	0.000
I25.1 Atherosclerotic heart disease	0.448	0.552	0.000
I23.8 Other current complications following acute myocardial infarction	0.447	0.553	0.000
I20.0 Unstable angina	0.445	0.555	0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.443	0.557	0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.443	0.557	0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.443	0.557	0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.443	0.557	0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.443	0.557	0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.443	0.557	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.568	0.432
I21.X Presumed acute myicardial infaction (unconfirmed)	0.430	0.570	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.429	0.571	0.000
I24.1 Dressler's syndrome	0.415	0.585	0.000
I25.4 Coronary artery aneurysm	0.402	0.597	0.000
I20.1 Angina pectoris with documented spasm	0.388	0.612	0.000
L41 Parapsoriasis	0.385	0.615	0.000
I22.0 Subsequent myocardial infarction of anterior wall	0.377	0.623	0.000
L43 Lichen planus	0.365	0.635	0.000
L44 Other papulosquamous disorders	0.362	0.637	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.362	0.637	0.000
E06 Thyroiditis	0.000	0.644	0.356
I25.5 Ischaemic cardiomyopathy	0.347	0.653	0.000
L42 Pityriasis rosea	0.344	0.656	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.325	0.675	0.000
I20.9 Angina pectoris, unspecified	0.325	0.675	0.000
C44.6 Skin of upper limb, including shoulder	0.318	0.682	0.000
L41.1 Pityriasis lichenoides chronica	0.298	0.702	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.297	0.703	0.000
L43.9 Lichen planus, unspecified	0.289	0.711	0.000
I21.4 Acute subendocardial myocardial infarction	0.282	0.718	0.000
L41.9 Parapsoriasis, unspecified	0.276	0.724	0.000
L41.8 Other parapsoriasis	0.276	0.724	0.000
L41.5 Retiform parapsoriasis	0.276	0.724	0.000
L41.4 Large plaque parapsoriasis	0.276	0.724	0.000
L41.3 Small plaque parapsoriasis	0.276	0.724	0.000
L41.2 Lymphomatoid papulosis	0.276	0.724	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.276	0.724	0.000
L43.3 Subacute (active) lichen planus	0.262	0.738	0.000
L43.2 Lichenoid drug reaction	0.262	0.738	0.000
L43.1 Bullous lichen planus	0.262	0.738	0.000
L43.0 Hypertrophic lichen planus	0.262	0.738	0.000
L44.9 Papulosquamous disorder, unspecified	0.260	0.740	0.000
L44.8 Other specified papulosquamous disorders	0.260	0.740	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.260	0.740	0.000
L44.3 Lichen ruber moniliformis	0.260	0.740	0.000
L44.2 Lichen striatus	0.260	0.740	0.000
L44.1 Lichen nitidus	0.260	0.740	0.000
L44.0 Pityriasis rubra pilaris	0.260	0.740	0.000
E06.4 Drug-induced thyroiditis	0.000	0.744	0.255
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.744	0.255
E06.1 Subacute thyroiditis	0.000	0.744	0.255
E06.0 Acute thyroiditis	0.000	0.744	0.255
E06.5 Other chronic thyroiditis	0.000	0.765	0.235
M07.3 Other psoriatic arthropathies	0.232	0.768	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.230	0.770	0.000
L43.8 Other lichen planus	0.228	0.772	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.000	0.773	0.227
M07.30 Other psoriatic arthropathies (Multiple sites)	0.226	0.774	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.000	0.787	0.213
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.000	0.787	0.213
M07.36 Other psoriatic arthropathies (Lower leg)	0.207	0.793	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.206	0.794	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.000	0.797	0.203
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.201	0.799	0.000
G03 Meningitis due to other and unspecified causes	0.000	0.800	0.200
G09 Sequelae of inflammatory diseases of central nervous system	0.000	0.800	0.200
G00 Bacterial meningitis, not elsewhere classified	0.000	0.801	0.199
E06.9 Thyroiditis, unspecified	0.001	0.806	0.194
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.190	0.810	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.000	0.812	0.188
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.000	0.812	0.188
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.000	0.812	0.188
C82.0 Small cleaved cell, follicular	0.187	0.813	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.183	0.817	0.000
G03.9 Meningitis, unspecified	0.000	0.819	0.181
G00.9 Bacterial meningitis, unspecified	0.000	0.828	0.172
M07.31 Other psoriatic arthropathies (Shoulder region)	0.172	0.828	0.000
G00.1 Pneumococcal meningitis	0.000	0.830	0.170
C43-C44 Melanoma and other malignant neoplasms of skin	0.169	0.831	0.000
M07.38 Other psoriatic arthropathies (Other)	0.167	0.833	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.167	0.833	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.167	0.833	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.165	0.835	0.000
G35 Multiple sclerosis	0.000	0.836	0.164
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.000	0.837	0.163
I21.9 Acute myocardial infarction, unspecified	0.162	0.838	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.000	0.840	0.160
G02.0 Meningitis in viral diseases classified elsewhere	0.000	0.840	0.160
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.000	0.840	0.159
G06.1 Intraspinal abscess and granuloma	0.000	0.845	0.155
C82.1 Mixed small cleaved and large cell, follicular	0.154	0.846	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.000	0.847	0.153
G04.1 Tropical spastic paraplegia	0.000	0.847	0.153
G04.0 Acute disseminated encephalitis	0.000	0.847	0.153
G01 Meningitis in bacterial diseases classified elsewhere	0.000	0.847	0.153
L57.0 Actinic keratosis	0.152	0.848	0.000
C82.2 Large cell, follicular	0.149	0.851	0.000
C82.3 Follicular lymphoma grade IIIa	0.148	0.852	0.000
G06.2 Extradural and subdural abscess, unspecified	0.000	0.852	0.148
G35-G37 Demyelinating diseases of the central nervous system	0.000	0.852	0.148
L57 Skin changes due to chronic exposure to nonionising radiation	0.146	0.854	0.000
G03.8 Meningitis due to other specified causes	0.000	0.856	0.144
G03.2 Benign recurrent meningitis [Mollaret]	0.000	0.856	0.144
G03.1 Chronic meningitis	0.000	0.856	0.144
G03.0 Nonpyogenic meningitis	0.000	0.856	0.144
G00.3 Staphylococcal meningitis	0.000	0.857	0.143
G00.2 Streptococcal meningitis	0.000	0.857	0.143
G00.0 Haemophilus meningitis	0.000	0.857	0.143
C82.6 Cutaneous follicle centre lymphoma	0.136	0.864	0.000
C82.5 Diffuse follicle centre lymphoma	0.136	0.864	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.865	0.135
C82.4 Follicular lymphoma grade IIIb	0.135	0.865	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.000	0.865	0.135
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.000	0.865	0.135
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.000	0.865	0.135
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.000	0.865	0.135
G02.1 Meningitis in mycoses	0.000	0.865	0.135
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.135	0.865	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.134	0.866	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.869	0.131
G06.0 Intracranial abscess and granuloma	0.000	0.870	0.130
E10.9 Without complications	0.000	0.870	0.130
E10.1 With ketoacidosis	0.000	0.871	0.129
E10-E14 Diabetes mellitus	0.000	0.873	0.127
Chapter XII Diseases of the skin and subcutaneous tissue	0.126	0.874	0.000
G37 Other demyelinating diseases of central nervous system	0.000	0.874	0.126
Chapter VI Diseases of the nervous system	0.000	0.875	0.125
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.125	0.875	0.000
E06.3 Autoimmune thyroiditis	0.001	0.877	0.123
E10.8 With unspecified complications	0.000	0.881	0.119
G00.8 Other bacterial meningitis	0.000	0.883	0.117
E10.2 With renal complications	0.000	0.884	0.115
E10.0 With coma	0.000	0.889	0.111
L57.5 Actinic granuloma	0.110	0.890	0.000
M07 Psoriatic and enteropathic arthropathies	0.109	0.891	0.000
G40-G47 Episodic and paroxysmal disorders	0.000	0.892	0.108
E40-E46 Malnutrition	0.000	0.892	0.108
G37.8 Other specified demyelinating diseases of central nervous system	0.000	0.894	0.106
G36 Other acute disseminated demyelination	0.000	0.894	0.106
G44.2 Tension-type headache	0.000	0.894	0.106
L57.3 Poikiloderma of Civatte	0.104	0.895	0.000
L57.2 Cutis rhomboidalis nuchae	0.104	0.895	0.000
L57.1 Actinic reticuloid	0.104	0.895	0.000
E10.4 With neurological complications	0.000	0.896	0.104
G44 Other headache syndromes	0.000	0.896	0.104
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.000	0.897	0.103
G41 Status epilepticus	0.000	0.898	0.102
E10.6 With other specified complications	0.000	0.898	0.102
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.901	0.099
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.099	0.901	0.000
L58 Radiodermatitis	0.098	0.902	0.000
G41.9 Status epilepticus, unspecified	0.000	0.902	0.098
E10.7 With multiple complications	0.000	0.903	0.097
L55 Sunburn	0.097	0.903	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.096	0.904	0.000
G45 Transient cerebral ischaemic attacks and related syndromes	0.000	0.904	0.096
G30-G32 Other degenerative diseases of the nervous system	0.000	0.904	0.095
T43.2 Other and unspecified antidepressants	0.095	0.905	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.093	0.907	0.000
L57.4 Cutis laxa senilis	0.092	0.907	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.909	0.091
E14 Unspecified diabetes mellitus	0.000	0.909	0.091
E46 Unspecified protein-energy malnutrition	0.000	0.909	0.091
T43.5 Other and unspecified antipsychotics and neuroleptics	0.090	0.910	0.000
G37.5 Concentric sclerosis [Balo]	0.000	0.910	0.090
G37.4 Subacute necrotising myelitis	0.000	0.910	0.090
G37.2 Central pontine myelinolysis	0.000	0.910	0.090
G37.1 Central demyelination of corpus callosum	0.000	0.910	0.090
G37.0 Diffuse sclerosis	0.000	0.910	0.090
G11 Hereditary ataxia	0.000	0.912	0.088
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.000	0.913	0.087
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.914	0.086
T36-T50 Poisoning by drugs, medicaments and biological substances	0.086	0.914	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.086	0.914	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.086	0.914	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.086	0.914	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.086	0.914	0.000
I20.8 Other forms of angina pectoris	0.085	0.914	0.000
G70-G73 Diseases of myoneural junction and muscle	0.000	0.916	0.084
G45.3 Amaurosis fugax	0.000	0.916	0.084
T42.4 Benzodiazepines	0.084	0.916	0.000
G45.4 Transient global amnesia	0.000	0.918	0.082
G14 Postpolio syndrome	0.000	0.919	0.081
G44.8 Other specified headache syndromes	0.000	0.919	0.081
T43.3 Phenothiazine antipsychotics and neuroleptics	0.081	0.919	0.000
L60-L75 Disorders of skin appendages	0.079	0.921	0.000
G45.0 Vertebro-basilar artery syndrome	0.000	0.921	0.079
G41.0 Grand mal status epilepticus	0.000	0.921	0.079
M07.6 Other enteropathic arthropathies	0.078	0.921	0.000
M07.5 Arthropathy in ulcerative colitis	0.078	0.921	0.000
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.078	0.921	0.000
M07.2 Psoriatic spondylitis	0.078	0.921	0.000
M07.1 Arthritis mutilans	0.078	0.921	0.000
M07.0 Distal interphalangeal psoriatic arthropathy	0.078	0.921	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.923	0.077
E45 Retarded development following protein-energy malnutrition	0.000	0.923	0.077
E43 Unspecified severe protein-energy malnutrition	0.000	0.923	0.077
E42 Marasmic kwashiorkor	0.000	0.923	0.077
E41 Nutritional marasmus	0.000	0.923	0.077
E40 Kwashiorkor	0.000	0.923	0.077
G46 Vascular syndromes of brain in cerebrovascular diseases	0.000	0.923	0.077
G45.1 Carotid artery syndrome (hemispheric)	0.000	0.923	0.076
G36.9 Acute disseminated demyelination, unspecified	0.000	0.924	0.076
G36.8 Other specified acute disseminated demyelination	0.000	0.924	0.076
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]	0.000	0.924	0.076
G36.0 Neuromyelitis optica [Devic]	0.000	0.924	0.076
G11.9 Hereditary ataxia, unspecified	0.000	0.924	0.076
E14.2 Withrenal complications	0.000	0.925	0.075
G44.1 Vascular headache, not elsewhere classified	0.000	0.925	0.075
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.075	0.925	0.000
E14.8 With unspecified complications	0.000	0.926	0.074
L71 Rosacea	0.074	0.926	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.000	0.926	0.074
G41.8 Other status epilepticus	0.000	0.926	0.074
G41.2 Complex partial status epilepticus	0.000	0.926	0.074
G41.1 Petit mal status epilepticus	0.000	0.926	0.074
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.073	0.927	0.000
G12 Spinal muscular atrophy and related syndromes	0.000	0.927	0.073
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.073	0.927	0.000
G30 Alzheimer's disease	0.000	0.927	0.073
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.072	0.928	0.000
L58.9 Radiodermatitis, unspecified	0.072	0.928	0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.071	0.929	0.000
L59.0 Erythema ab igne [dermatitis ab igne]	0.071	0.929	0.000
L71.9 Rosacea, unspecified	0.071	0.929	0.000
L58.1 Chronic radiodermatitis	0.070	0.929	0.000
L58.0 Acute radiodermatitis	0.070	0.929	0.000
L10-L14 Bullous disorders	0.070	0.930	0.000
E10.5 With peripheral circulatory complications	0.000	0.930	0.070
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.070	0.930	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.930	0.070
L55.9 Sunburn, unspecified	0.069	0.930	0.000
L55.8 Other sunburn	0.069	0.930	0.000
L55.2 Sunburn of third degree	0.069	0.930	0.000
L55.1 Sunburn of second degree	0.069	0.930	0.000
L55.0 Sunburn of first degree	0.069	0.930	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.000	0.931	0.069
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.069	0.931	0.000
T42.0 Hydantoin derivatives	0.069	0.931	0.000
L56.4 Polymorphous light eruption	0.069	0.931	0.000
L56.3 Solar urticaria	0.069	0.931	0.000
L56.2 Photocontact dermatitis [berloque dermatitis]	0.069	0.931	0.000
L56.1 Drug photoallergic response	0.069	0.931	0.000
L56.0 Drug phototoxic response	0.069	0.931	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.931	0.069
G45.2 Multiple and bilateral precerebral artery syndromes	0.000	0.931	0.069
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.068	0.931	0.000
G45.8 Other transient cerebral ischaemic attacks and related syndromes	0.000	0.932	0.068
T42.3 Barbiturates	0.068	0.932	0.000
E14.1 With ketoacidosis	0.000	0.932	0.068
T50.4 Drugs affecting uric acid metabolism	0.068	0.932	0.000
L70 Acne	0.068	0.932	0.000
T43.9 Psychotropic drug, unspecified	0.067	0.933	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.067	0.933	0.000
G44.3 Chronic posttraumatic headache	0.000	0.933	0.066
G10 Huntington's disease	0.000	0.933	0.066
I21.0 Acute transmural myocardial infarction of anterior wall	0.067	0.933	0.000
G70 Myasthenia gravis and other myoneural disorders	0.000	0.933	0.067
E14.5 With peripheral circulatory complications	0.000	0.934	0.066
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.066	0.934	0.000
G11.4 Hereditary spastic paraplegia	0.000	0.934	0.066
E12.9 Without complications	0.000	0.934	0.065
E12.8 With unspecified complications	0.000	0.934	0.065
E12.7 With multiple complications	0.000	0.934	0.065
E12.6 With other specified complications	0.000	0.934	0.065
E12.5 With peripheral circulatory complications	0.000	0.934	0.065
E12.4 With neurological complications	0.000	0.934	0.065
E12.3 With ophthalmic complications	0.000	0.934	0.065
E12.2 With renal complications	0.000	0.934	0.065
E12.1 With ketoacidosis	0.000	0.934	0.065
E12.0 With coma	0.000	0.934	0.065
E50-E64 Other nutritional deficiencies	0.000	0.934	0.066
E14.7 With multiple complications	0.000	0.935	0.065
E14.0 With coma	0.000	0.935	0.065
E04 Other non-toxic goitre	0.001	0.935	0.064
T37.8 Other specified systemic anti-infectives and antiparasitics	0.064	0.936	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.063	0.936	0.000
L68 Hypertrichosis	0.063	0.937	0.000
G11.8 Other hereditary ataxias	0.000	0.937	0.063
G11.3 Cerebellar ataxia with defective DNA repair	0.000	0.937	0.063
G11.2 Late-onset cerebellar ataxia	0.000	0.937	0.063
G11.1 Early-onset cerebellar ataxia	0.000	0.937	0.063
G11.0 Congenital nonprogressive ataxia	0.000	0.937	0.063
E65-E68 Obesity and other hyperalimentation	0.000	0.937	0.063
E13 Other specified diabetes mellitus	0.000	0.937	0.063
E14.3 With ophthalmic complications	0.000	0.937	0.063
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.062	0.938	0.000
E14.6 With other specified complications	0.000	0.938	0.062
E15 Nondiabetic hypoglycaemic coma	0.000	0.938	0.062
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.062	0.938	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.062	0.938	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.062	0.938	0.000
T42.2 Succinimides and oxazolidinediones	0.062	0.938	0.000
T50.7 Analeptics and opioid receptor antagonists	0.061	0.938	0.000
T50.5 Appetite depressants	0.061	0.938	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.061	0.938	0.000
T50.1 Loop [high-ceiling] diuretics	0.061	0.938	0.000
T50.0 Mineralocorticoids and their antagonists	0.061	0.938	0.000
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere	0.000	0.939	0.061
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.060	0.939	0.000
G72 Other myopathies	0.000	0.940	0.060
G30.0 Alzheimer's disease with early onset	0.000	0.940	0.060
E14.4 With neurological complications	0.000	0.940	0.060
T50.6 Antidotes and chelating agents, not elsewhere classified	0.059	0.941	0.000
T36 Poisoning by systemic antibiotics	0.059	0.941	0.000
T42.1 Iminostilbenes	0.058	0.941	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.058	0.941	0.000
T50.8 Diagnostic agents	0.058	0.942	0.000
T43.6 Psychostimulants with abuse potential	0.058	0.942	0.000
G30.9 Alzheimer's disease, unspecified	0.000	0.942	0.058
L70.0 Acne vulgaris	0.058	0.942	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.057	0.943	0.000
L75 Apocrine sweat disorders	0.057	0.943	0.000
L74 Eccrine sweat disorders	0.057	0.943	0.000
L67 Hair colour and hair shaft abnormalities	0.057	0.943	0.000
L64 Androgenic alopecia	0.057	0.943	0.000
L63 Alopecia areata	0.057	0.943	0.000
L62 Nail disorders in diseases classified elsewhere	0.057	0.943	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.943	0.057
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.056	0.943	0.000
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.056	0.943	0.000
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.056	0.943	0.000
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.056	0.943	0.000
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.056	0.943	0.000
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.056	0.943	0.000
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.056	0.943	0.000
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.056	0.943	0.000
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.056	0.943	0.000
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.056	0.943	0.000
M07.19 Arthritis mutilans (Site unspecified)	0.056	0.943	0.000
M07.18 Arthritis mutilans (Other)	0.056	0.943	0.000
M07.17 Arthritis mutilans (Ankle and foot)	0.056	0.943	0.000
M07.16 Arthritis mutilans (Lower leg)	0.056	0.943	0.000
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.056	0.943	0.000
M07.14 Arthritis mutilans (Hand)	0.056	0.943	0.000
M07.13 Arthritis mutilans (Forearm)	0.056	0.943	0.000
M07.12 Arthritis mutilans (Upper arm)	0.056	0.943	0.000
M07.11 Arthritis mutilans (Shoulder region)	0.056	0.943	0.000
M07.10 Arthritis mutilans (Multiple sites)	0.056	0.943	0.000
M07.29 Psoriatic spondylitis (Site unspecified)	0.056	0.943	0.000
M07.28 Psoriatic spondylitis (Other)	0.056	0.943	0.000
M07.27 Psoriatic spondylitis (Ankle and foot)	0.056	0.943	0.000
M07.26 Psoriatic spondylitis (Lower leg)	0.056	0.943	0.000
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.056	0.943	0.000
M07.24 Psoriatic spondylitis (Hand)	0.056	0.943	0.000
M07.23 Psoriatic spondylitis (Forearm)	0.056	0.943	0.000
M07.22 Psoriatic spondylitis (Upper arm)	0.056	0.943	0.000
M07.21 Psoriatic spondylitis (Shoulder region)	0.056	0.943	0.000
M07.20 Psoriatic spondylitis (Multiple sites)	0.056	0.943	0.000
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.056	0.943	0.000
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.056	0.943	0.000
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.056	0.943	0.000
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.056	0.943	0.000
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.056	0.943	0.000
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.056	0.943	0.000
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.056	0.943	0.000
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.056	0.943	0.000
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.056	0.943	0.000
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.056	0.943	0.000
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.056	0.943	0.000
M07.58 Arthropathy in ulcerative colitis (Other)	0.056	0.943	0.000
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.056	0.943	0.000
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.056	0.943	0.000
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.056	0.943	0.000
M07.54 Arthropathy in ulcerative colitis (Hand)	0.056	0.943	0.000
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.056	0.943	0.000
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.056	0.943	0.000
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.056	0.943	0.000
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.056	0.943	0.000
M07.69 Other enteropathic arthropathies (Site unspecified)	0.056	0.943	0.000
M07.68 Other enteropathic arthropathies (Other)	0.056	0.943	0.000
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.056	0.943	0.000
M07.66 Other enteropathic arthropathies (Lower leg)	0.056	0.943	0.000
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.056	0.943	0.000
M07.64 Other enteropathic arthropathies (Hand)	0.056	0.943	0.000
M07.63 Other enteropathic arthropathies (Forearm)	0.056	0.943	0.000
M07.62 Other enteropathic arthropathies (Upper arm)	0.056	0.943	0.000
M07.61 Other enteropathic arthropathies (Shoulder region)	0.056	0.943	0.000
M07.60 Other enteropathic arthropathies (Multiple sites)	0.056	0.943	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.056	0.944	0.000
G46.3 Brain stem stroke syndrome	0.000	0.944	0.056
E44.1 Mild protein-energy malnutrition	0.000	0.944	0.056
E44.0 Moderate protein-energy malnutrition	0.000	0.944	0.056
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.056	0.944	0.000
G46.4 Cerebellar stroke syndrome	0.000	0.944	0.056
G46.8 Other vascular syndromes of brain in cerebrovascular diseases	0.000	0.944	0.055
G46.6 Pure sensory lacunar syndrome	0.000	0.944	0.055
G46.5 Pure motor lacunar syndrome	0.000	0.944	0.055
G46.2 Posterior cerebral artery syndrome	0.000	0.944	0.055
G46.1 Anterior cerebral artery syndrome	0.000	0.944	0.055
G46.0 Middle cerebral artery syndrome	0.000	0.944	0.055
G31.2 Degeneration of nervous system due to alcohol	0.000	0.945	0.055
G70.9 Myoneural disorder, unspecified	0.000	0.945	0.055
G46.7 Other lacunar syndromes	0.000	0.946	0.054
E16 Other disorders of pancreatic internal secretion	0.000	0.946	0.054
N85.8 Other specified noninflammatory disorders of uterus	0.054	0.946	0.000
L10 Pemphigus	0.054	0.946	0.000
G30.1 Alzheimer's disease with late onset	0.000	0.946	0.054
L60 Nail disorders	0.054	0.946	0.000
L71.8 Other rosacea	0.054	0.946	0.000
L71.0 Perioral dermatitis	0.053	0.946	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.000	0.946	0.053
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.000	0.946	0.053
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.000	0.946	0.053
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.000	0.946	0.053
L71.1 Rhinophyma	0.053	0.947	0.000
L70.9 Acne, unspecified	0.053	0.947	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.947	0.053
G70.0 Myasthenia gravis	0.000	0.947	0.053
L50-L54 Urticaria and erythema	0.053	0.947	0.000
G12.9 Spinal muscular atrophy, unspecified	0.000	0.947	0.052
G12.8 Other spinal muscular atrophies and related syndromes	0.000	0.947	0.052
G12.1 Other inherited spinal muscular atrophy	0.000	0.947	0.052

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations